BLASTOID VARIANT MANTLE CELL LYMPHOMA
Clinical trials for BLASTOID VARIANT MANTLE CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new BLASTOID VARIANT MANTLE CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for BLASTOID VARIANT MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo therapy targets aggressive lymphoma in young patients
Disease control OngoingThis study tests a combination of targeted therapy (ibrutinib) and immunotherapy (rituximab) followed by strong chemotherapy in young patients with newly diagnosed mantle cell lymphoma, an aggressive blood cancer. The goal is to see if this approach improves response rates while …
Matched conditions: BLASTOID VARIANT MANTLE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug combo shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis phase II trial is testing two oral drugs, venetoclax and acalabrutinib, in 32 people with mantle cell lymphoma that has returned or not responded to prior treatment. The goal is to see if the combination can shrink tumors and control the disease. Both drugs work by blocking …
Matched conditions: BLASTOID VARIANT MANTLE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC